Takeaway
Tau pathology occurs in carriers of apolipoprotein E ε4 (APOEε4) and is independent of
amyloid-β involvement.
Why this matters
APOEε4 is a well-established genetic risk factor for Alzheimer’s disease (AD) that causes amyloid-β deposition, but its association with cerebral tau pathology is unclear.